Regulation and characterization of the interferon-α present in patients with advanced human immunodeficiency virus type 1 disease

Journal of Interferon and Cytokine Research

Volumn 16, Issue 2, 1996, Pages 127-137

  Swindells, Susan ^a   Baldwin, Tonia ^a   Kelly, Colleen ^a   Baca Regen, Lisa ^a   Loomis, Larry ^b   Post, Diane ^b   Brichacek, Beda ^a   Stevenson, Mario ^a   Dominguez, Edward A ^a   Reddy, Ramakrishna ^a,c   Klein, Rose ^c   Liao, Mei June ^d   Testa, Douglas ^d   Mcdonald, Thomas ^a   Bellanti, Joseph ^e   Skurkovich, Simon ^f   Gendelman, Howard E ^a,b,g  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b New Horizons Diagnostics Corporation   (United States)

^c AMERICAN RED CROSS   (United States)

^d Interferon Sciences Inc   (United States)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Advanced Biotherapy   (United States)

^g UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBODY; CD4 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL ACTIVITY; APHERESIS; ARTICLE; BACTEREMIA; BIOASSAY; CASE REPORT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOADSORPTION; IMMUNOBLOTTING; IMMUNODIFFUSION; MALE; MONOCYTE; PRECIPITATION; PRIORITY JOURNAL; VIRION;

EID: 0030048043     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.127     Document Type: Article

References (60)

1. FAUCI, A.S. (1993). Multifactorial nature of human immunodeficiency virus disease. Implications for therapy. Science 262, 1011-1018.
2. SAAG, M.S. (1994). Evolving understanding of the immunopathogenesis of HIV. AIDS Res. Hum. Retroviruses 10, 887-892.
3. CLARK, S.J., SAAG, M.S., DECKER, W.D., CAMPBELL-HILL, S., ROBERSON, J.L., PETER, B.S., VELKAMP, P.J., KAPPES, J.L., HAHN, B.H., and SHAW, G.M. (1991). High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324, 954-960.
4. LIFSON, A.R., RUTHERFORD, G.W., and JAFFE, H.W. (1988). The natural history of human immunodeficiency virus infection. J. Infect. Dis. 158, 1360-1367.
5. BARON, S., TYRING, S.K., FLEISCHMANN, W.R., JR., COPPENHAVER, D.H., NIESEL, D.W., KLIMPEL, G.R., STANTON, G.J., and HUGHES, T.K. (1991). The interferons: mechanisms of action and clinical applications. JAMA 266, 1375-1383.
6. SAMUEL, C.E. (1991). Antiviral actions of interferon: interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183, 1-11.
7. GENDELMAN, H.E., SKILLMAN, D.R., and MELTZER, M.S. (1992). Interferon alpha (IFN)-macrophage interactions in human immunodeficiency virus (HIV) infection: role of IFN in the tempo and progression of HIV disease. Int. Rev. Immunol. 8, 43-54.
8. LAU, A.S., and WILLIAMS, B.R.G. (1990). The role of interferon and tumor necrosis factor in the pathogenesis of AIDS. J. Exp. Pathol. 5, 111-121.
9. MEYLAN, P.R.A., MUNIS, J.R., GUATELLI, J.C., RICHMAN, D.D., and KORNBLUTH, R.S. (1993). Mechanisms for the inhibition of HIV replication by interferon-α, β, and γ in primary human macrophages. Virology 193, 138-148.
10. SHIRZAI, Y., and PITHA, P.M. (1992). Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J. Virol. 66, 1321-1328.
11. FAN, S.X., TURPIN, J.A., ARONOVITZ, J.A., and MELTZER, M.S. (1994). Interferon-γ protects primary monocytes against infection with human immunodeficiency virus type 1. J. Leukoc. Biol. 56, 362-368.
12. BACA-REGEN, L., HEINZINGER, N., STEVENSON, M., and GENDELMAN, H.E. (1994). Interferon-alpha induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in HIV-1-infected monocytes. J. Virol. 68, 7559-7565.
13. FRANCIS, M.L., MELTZER, M.S., and GENDELMAN, H.E. (1992). Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Res. Hum. Retroviruses 8, 199-207.
14. DESTEFANO, E., FRIEDMAN, R.M., FRIEDMAN-KIEN, A.E., GOEDERT, J.J., HENRICKSEN, D., PREBLE, O.T., SONNABEND, J.A., and VILCEK, J. (1982). Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J. Infect. Dis. 146, 451-459.
15. PREBLE, O.T., ROOK, A.H., QUINNAN, G.V., VILCEK, J., FRIEDMAN, R.M., STEIS, R., GELMANN, E.P., and SONNABEND, J.A. (1984). Role of interferon in AIDS. Ann N.Y. Acad. Sci. 437, 65-75.
16. EYSTER, M.E., GOEDERT, J., POON, M.C., and PREBLE, O.T. (1983). Acid-labile alpha interferon. A possible preclinical marker of the acquired immunodeficiency syndrome in hemophilia. N. Engl. J. Med. 309, 583-586.
17. VADHAN-RAJ, R., WONG, G., GNECCO, C., CUNNINGHAM-RUNDLES, S., KRIM, M., REAL, F.X., OETTGEN, H.E., and KROWN, S.E. (1986). Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome. Cancer Res. 46, 417-425.
18. 2-microglobulin in asymptomatic HIV-infected individuals. AIDS 5, 289-293.
19. FUCHS, D., SHEARER, G.M., BOSWELL, R.N., LUCEY, D.R., CLERICI, M., REIBNEGGER, G., WERNER, E.R., ZAJAC, R.A., and WACHTER, H. (1991). Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. AIDS 5, 209-213.
20. GOEDERT, J.J., KESSLER, C.M., ALEDORT, L.M., BIGGAR, R.J., ANDES, W.A., WHITE, G.C., DRUMMOND, J.E., VAIDYA, K., MANN, D.L., EYSTER, M.E., RAGNI, M.V., LEDERMAN, M.M., COHEN, A.R., BRAY, G.L., ROSENBERG, P.S., FRIEDMAN, R.M., HILLGARTNER, M.W., BLATTNER, W.A., KRONER, B., and GAIL, M.H. (1989). A prospective study of human immunodeficiency virus type I infection and the development of AIDS in subjects with hemophilia. N. Engl. J. Med. 321, 1141-1148.
21. MILDVAN, D., MACHADO, S.G., WILTES, I., and GROSSBERG, S.E. (1992). Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and AIDS-related complex. Lancet 339, 453-456.
22. GRUNFELD, C., and FEINGOLD, K.R. (1992). The role of the cytokines, interferon alpha, and tumor necrosis factor in the hypertriglyceridemia and wasting of AIDS. J. Nutr. 122(3 Suppl):749-753.
23. GRUNFELD, C., KOTLER, D.P., SHIGENAGA, J.K., DOERRLER, W., TIERNEY, A., WANG, J., PIERSON, R.R.N., and FEINGOLD, K.R. (1991). Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am. J. Med. 90, 154-162.
24. COHEN, J. (1993). AIDS research: the mood is uncertain. Science 260, 1254-1255.
25. SKURKOVICH, S., SKURKOVICH, B., and BELLANTI, J.A. (1987). A unifying model of the immunoregulatory role of the interferon system: can interferon produce disease in humans? Clin. Immunol. Immunopathol. 43, 362-373.
26. SKURKOVICH, S., SKURKOVICH, B., and BELLANTI, J.A. (1993). A disturbance of interferon synthesis with the hyperproduction of unusual kinds of interferon can trigger autoimmune disease and play a pathogenetic role in AIDS: the removal of these interferons can be therapeutic. Med. Hypoth. 41, 177-185.
27. BELLANTI, J.A., SKURKOVICH, S.V., and PETERS, S.M. (1987). Preliminary clinical trial of anti-alpha IFN in patients with AIDS: a possible approach for immune enhancement. III International Conference on AIDS, Washington, DC, June 1-5, Abstract MP.1.III.
28. GENDELMAN, H.E., BALDWIN, T., BACA-REGEN, L., SWINDELLS, S., LOOMIS, L., and SKURKOVICH, S. (1994). Regulation of HIV1 replication by interferon alpha: from laboratory to bedside. Res. Immunol. 125, 679-684.
29. FAMILLETTI, P.C., RUBINSTEIN, S., and PESTKA, S. (1981). A convenient and rapid cytopathic effect inhibition assay for interferon. Methods Enzymol. 78, 387-394.
30. MILNER, L.S., HOUSER, M.T., KOLBECK, P.C., ANTONSON, D.L., MCDONALD, T.L., MARKIN, R.S., and SHAW, B.W., JR. (1993). Glomerular injury in end-stage liver disease - role of circulating IgG and IgM immune complexes. Pediatr. Nephrol. 7, 6-10.
31. HO, D.D., MOUDGIL, T., and ALAM, M. (1989). Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321, 1621-1625.
32. KALTER, D.C., NAKAMURA, M., TURPIN, J.A., BACA, L.M., DIEFFENBACH, C., RALPH, P., GENDELMAN, H.E., and MELTZER, M.S. (1991). Enhanced HIV replication in MCSF-treated monocytes. J. Immunol. 146, 298-306.
33. STEVENSON, M.S., HAGGERTY, S., LAMONICA, C.A., MEIER, C.M., WELCH, S.K., and WASIAK, A.J. (1990). Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J. Virol. 64, 2421-2425.
34. MYERS, G. (1994). HIV Sequence Database, Los Alamos, NM: Los Alamos National Laboratory.
35. LANGER, J.A., and PESTKA, S. (1984). Purification, bacterial expression, and biological activities of the human interferons. J. Invest. Dermatol. (Suppl):128-136.
36. GENDELMAN, H.E., ORENSTEIN, J.M., MARTIN, M.A., FERRUA, C., MITRA, R., PHIPPS, T., WAHL, L.A., LANE, H.C., FAUCI, A.S., BURKE, D.S., SKILLMAN, D.S., and MELTZER, M.S. (1988). Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167, 1428-1441.
37. GENDELMAN, H.E., and MORAHAN, P.S. (1992). Macrophages in viral infections. In: C.E. Lewis and J.O.D. McGee (eds.) The Macrophage. New York: IRL Press, pp. 157-195.
38. GENDELMAN, H.E., BACA, L.M., KUBRAK, C.A., GENIS, P., BURROUS, S., FRIEDMAN, R.M., JACOBS, D., and MELTZER, M.S. (1992). Induction of IFN-α in peripheral blood mononuclear cells by HIV-1-infected monocytes restricted antiviral activity of the HIV-induced IFN. J. Immunol. 148, 422-429.
39. GENDELMAN, H.E., BACA, L.M., TURPIN, J., KALTER, D.C., HANSEN, B., ORENSTIN, J.M., DIEFFENBACH, C., FRIEDMAN, R.M., and MELTZER, M.S. (1990). Regulation of HIV replication in infected monocytes by interferon α: mechanisms for viral restriction. J. Immunol. 145, 2669-2677.
40. ISAACS, A., LINDENMANN, J. (1957). Virus interference. I. The interferon. Proc. R. Soc. Lond. [B] 147, 258-267.
41. LAURENCE, J. (1990). Immunology of HIV infection. I. Biology of the interferons. AIDS Res. Hum. Retroviruses 6, 1149-1156.
42. TAYLOR, J.L., and GROSSBERG, S.E. (1990). Recent progress in interferon research: molecular mechanisms of regulation, action, and virus circumvention. Virus Res. 15, 1-26.
43. PESTKA, S., LANGER, J.A., ZOON, K.C., and SAMUEL, C.E. (1987). Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
44. ZOON, K.C. (1987). Human interferons: structure and function. Interferon 9, 1-12.
45. BACA, L.M., GENIS, P., KALVAKOLANU, D., SEN, G., MELTZER, M.S., ZHOU, A., SILVERMAN, R., and GENDELMAN, H.E. (1994). Regulation of interferon-α-inducible cellular genes in human immunodeficiency virus-infected monocytes. J. Leukoc. Biol. 55, 299-309.
46. KORNBLUTH, R.S., OH, P.S., MUNIS, J.S., CLEVELAND, P.S., and RICHMAN, D.D. (1990). The role of interferons in the control of HIV replication in macrophages. Clin. Immunol. Immunopathol. 54, 200-219.
47. BELARDELLI, F., VIGNAUX, F., PRIETTI, E., and GRESSER, I. (1984). Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis and encephalomyocarditis viruses. Proc. Natl. Acad. Sci. USA 81, 602-606.
48. PESTKA, S., LANGER, J.A., ZOON, K.C., and SAMUEL, C.E. (1987). Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
49. STAEHELI, P. (1990). Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38, 147-200.
50. NARA, P., MERGES, M., CONLEY, S., SHAW, G., and GENDELMAN, H. (1992). The acute-phase response to HIV-1 during acute infection: an abnormal cytokine response? First National Conference on HIV-1, Washington, DC. December 12, Abstract 358.
51. LANE, H.C., KOVACS, J.A., FEINBERG, J., HERPIN, B., DAVEY, V., WALKER, R., DEYTON, L., METCALF, J.A., BASELER, M., SALZMAN, N., MANISCHEWITZ, J., QUINNAN, G., MASUR, H., and FAUCI, A.S. (1988). Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma. Lancet 2, 1218-1222.
52. LANE, H.C., DAVEY, V., KOVACS, J.A., FEINBERG, J., METCALF, J.A., HERPIN, B., WALKER, R., DEYTON, L., DAVEY, R., FALLOON, J., POLIS, M.A., SALZMAN, N.P., BASELER, M., MASUR, H., and FAUCI, A.S. (1990). Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection: a randomized, placebo-controlled trial. Ann. Intern. Med. 112, 805-811.
53. KROWN, S.E., REAL, F.X., CUNNINGHAM-RUNDLES, S., MYSKOWSKI, P.L., KOZINER, B., FEIN, S., MITTELMAN, A., OETTGEN, H.F., SAFAI, B. (1983). Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N. Engl. J. Med. 308, 1071-1076.
54. DEWIT, R., SCHATTENKERK, J.K.M.E., BOUCHER, C.A.B., BAKKER, P.J.M., VEENHOF, K.H.M., and DANNER, S.A. (1988). Clinical and virological effects of high-dose recombinant interferon-α in disseminated AIDS-related Kaposi's sarcoma. Lancet 2, 1214-1217.
55. EDLIN, B.R., ST. CLAIR, M.H., PITHA, P.M., WHALING, S.M., KING, D.M., BITRAN, J.D., and WEINSTEIN, R.A. (1992). In vitro resistance to zidovudine and alpha interferon in HIV-1 isolates from patients: correlations with treatment duration and response. Ann. Intern. Med. 117, 457-460.
56. LAU, A.S., READ, S.E., and WILLIAMS, B.R.G. (1988). Downregulation of interferon α but not γ receptor expression in vivo in the acquired immunodeficiency syndrome. J. Clin. Invest. 82, 1415-1421.
57. MITCHELL, W.M., MONTEFIORI, D.C., SOBOL, R.W., LI, S.W., REICHENBACH, S.W., REICHENBACH, N.L., CHARABULA, R., PFEIDERER, W., ROBINSON, W.E., and SUHADOLNIK, R.J. (1989). Structure/function relationships of 2-5A analogues for inhibition of HIV-1 reverse transcriptase and infection in vitro. J. Cell Biochem. 13B, 305.
58. LIU, D.K., and OWENS, C.F. (1987). Inhibition of viral reverse transcriptase by 2′,5′-oligoadenylates. Biochem. Biophys. Res. Commun. 145, 291-297.
59. BROOCKMEYER, N.H., MERTINIS, L., SPATZ, D., TILLMANN, I., and GOOS, M. (1992). Endogenous interferon plasma levels and antipyrine pharmacokinetics in patients with viral infections. J. Clin. Pharmacol. Ther. Toxicol. 30, 531-533.
60. GRINGERI, A., SANTAGOSTINO, E., MANNUCCI, P.M., SIRACUSANO, L., MARINONI, A., CRISCUOLO, M., CARCAGNO, M., FALL, L.-S., M'BIKA, J.-P., BIZZINI, B., and ZAGURY, D. (1995). Anti-alpha interferon immunization: Safety and immunogenicity in asymptomatic HIV positive patients at high risk of disease progression. Cell. Mol. Biol. 41, 381-387.